| Nov 12 |
KALA BIO GAAP EPS of -$1.93 beats by $0.50
|
| Nov 12 |
KALA BIO Reports Third Quarter 2024 Financial Results and Provides Corporate Update
|
| Aug 8 |
KALA BIO to Present at H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
|
| Aug 6 |
KALA BIO GAAP EPS of -$3.16 beats by $1.25
|
| Aug 6 |
KALA BIO GAAP EPS of -$3.16
|
| Aug 6 |
KALA BIO Reports Second Quarter 2024 Financial Results and Provides Corporate Update
|
| Jun 27 |
Kala Pharmaceuticals to sell 1.197M shares at $5.85 in private placement
|
| Jun 27 |
KALA BIO Announces $12,500,000 Private Placement
|
| May 29 |
KALA BIO to Present at Jefferies Global Healthcare Conference
|
| May 21 |
Wall Street Analysts Just Trimmed Price Target for KALA BIO, Inc. (NASDAQ:KALA)
|
